Gene: ZCCHC10
Official Full Name: zinc finger CCHC-type containing 10provided by HGNC
Gene Summary: Predicted to enable nucleic acid binding activity and zinc ion binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12443 | ZCCHC10 Knockout cell line (HeLa) | Human | ZCCHC10 | 1:3~1:6 | Negative | Online Inquiry |
KO12444 | ZCCHC10 Knockout cell line (HCT 116) | Human | ZCCHC10 | 1:2~1:4 | Negative | Online Inquiry |
KO12445 | ZCCHC10 Knockout cell line (HEK293) | Human | ZCCHC10 | 1:3~1:6 | Negative | Online Inquiry |
KO12446 | ZCCHC10 Knockout cell line (A549) | Human | ZCCHC10 | 1:3~1:4 | Negative | Online Inquiry |
ZCCHC10 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to study the role of the zinc finger CCHC-type containing 10 protein, which is implicated in various cellular processes, including DNA repair, RNA metabolism, and immune response regulation. These cell lines provide researchers with a powerful tool to explore the functional consequences of ZCCHC10 loss-of-function, enabling detailed investigations into its biological significance.
The mechanism of action for these cell lines involves the CRISPR/Cas9 gene-editing technology, which effectively introduces targeted mutations in the ZCCHC10 gene, resulting in complete gene knockout. This precise alteration allows for the observation of phenotypic changes and mechanistic pathways that may reveal new insights into disease models and therapeutic targets. By using ZCCHC10 knockout models, researchers can investigate pathways associated with cancer progression, increasing our understanding of tumor biology and potentially leading to innovative treatment strategies.
The scientific importance of ZCCHC10 Gene Knockout Cell Lines is underscored by their wide-ranging applications in both basic research and clinical settings. They facilitate the study of various genetic interactions and pathway dependencies, thus holding promise for drug development and personalized medicine initiatives. Furthermore, their use in high-throughput screening assays can expedite the discovery of small molecules or biologics that modulate ZCCHC10 activity.
What sets ZCCHC10 Gene Knockout Cell Lines apart from alternative models is their specificity and reliability. This product provides a well-characterized genetic background, ensuring reproducibility and consistency in experiments. Additionally, their ease of use and compatibility with common laboratory techniques streamline workflows, making them ideal for busy laboratories engaged in critical research.
For researchers and clinicians invested in advancing our understanding of genetic regulation and its implications for health and disease, ZCCHC10 Gene Knockout Cell Lines represent a valuable resource. By incorporating these cell lines into your research, you gain access to a wealth of possibilities for exploration and innovation.
Our company, a leader in the field of genetic engineering, prides itself on delivering high-quality biological products backed by extensive research and technological innovation, ensuring that our customers have the tools necessary to push the boundaries of scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.